25 XP   0   0   10

Medical Developments International
Buy, Hold or Sell?

Let's analyse Medical Developments International together

PenkeI guess you are interested in Medical Developments International. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Medical Developments International. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Medical Developments International

I send you an email if I find something interesting about Medical Developments International.

Quick analysis of Medical Developments International (30 sec.)










What can you expect buying and holding a share of Medical Developments International? (30 sec.)

How much money do you get?

How much money do you get?
A$0.78
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
A$0.94
Expected worth in 1 year
A$2.06
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
A$2.34
Return On Investment
424.7%

For what price can you sell your share?

Current Price per Share
A$0.55
Expected price per share
A$0 - A$0.635
How sure are you?
50%

1. Valuation of Medical Developments International (5 min.)




Live pricePrice per Share (EOD)

A$0.55

Intrinsic Value Per Share

A$-3.78 - A$-1.71

Total Value Per Share

A$-2.84 - A$-0.77

2. Growth of Medical Developments International (5 min.)




Is Medical Developments International growing?

Current yearPrevious yearGrowGrow %
How rich?$52m$36.6m$15.3m29.5%

How much money is Medical Developments International making?

Current yearPrevious yearGrowGrow %
Making money-$3.5m-$7.9m$4.3m121.2%
Net Profit Margin-17.3%-56.5%--

How much money comes from the company's main activities?

3. Financial Health of Medical Developments International (5 min.)




What can you expect buying and holding a share of Medical Developments International? (5 min.)

Welcome investor! Medical Developments International's management wants to use your money to grow the business. In return you get a share of Medical Developments International.

What can you expect buying and holding a share of Medical Developments International?

First you should know what it really means to hold a share of Medical Developments International. And how you can make/lose money.

Speculation

The Price per Share of Medical Developments International is A$0.55. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Medical Developments International.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Medical Developments International, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.94. Based on the TTM, the Book Value Change Per Share is A$0.28 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.31 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Medical Developments International.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.04-7.6%-0.04-7.6%-0.09-16.7%-0.04-7.9%-0.02-3.1%
Usd Book Value Change Per Share0.1832.4%0.1832.4%-0.08-14.8%0.0916.3%0.058.8%
Usd Dividend Per Share0.2035.6%0.2035.6%0.000.2%0.1017.8%0.059.5%
Usd Total Gains Per Share0.3768.0%0.3768.0%-0.08-14.7%0.1934.0%0.1018.3%
Usd Price Per Share0.50-0.50-0.93-2.44-2.55-
Price to Earnings Ratio-11.92--11.92--10.16-395.43-488.89-
Price-to-Total Gains Ratio1.33-1.33--11.60-150.68-207.70-
Price to Book Ratio0.82-0.82-2.20-6.57-12.46-
Price-to-Total Gains Ratio1.33-1.33--11.60-150.68-207.70-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.35222
Number of shares2839
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.200.10
Usd Book Value Change Per Share0.180.09
Usd Total Gains Per Share0.370.19
Gains per Quarter (2839 shares)1,061.64531.29
Gains per Year (2839 shares)4,246.552,125.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1222320244237110910162115
2444640488484221920324240
36668607112731332830476365
48891809516978443840638490
51111410119212255547507910615
61333712143254726656609512740
71556014166297197766711014865
81778216190339668875812616990
92000518214382139985914219115
10222282023842460110941015821240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%7.03.00.070.0%17.03.00.085.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%16.04.00.080.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.07.065.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%19.01.00.095.0%

Fundamentals of Medical Developments International

About Medical Developments International

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices. The company also provides asthma and COPD products, such as space chambers and silicone face masks. The company was founded in 1971 and is headquartered in Scoresby, Australia.

Fundamental data was last updated by Penke on 2024-04-01 22:32:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Medical Developments International.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Medical Developments International earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Medical Developments International to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -17.3% means that $-0.17 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Medical Developments International:

  • The MRQ is -17.3%. The company is making a huge loss. -2
  • The TTM is -17.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-17.3%TTM-17.3%0.0%
TTM-17.3%YOY-56.5%+39.2%
TTM-17.3%5Y-23.4%+6.0%
5Y-23.4%10Y-7.1%-16.3%
1.1.2. Return on Assets

Shows how efficient Medical Developments International is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medical Developments International to the Drug Manufacturers - Specialty & Generic industry mean.
  • -5.1% Return on Assets means that Medical Developments International generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Medical Developments International:

  • The MRQ is -5.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.1%TTM-5.1%0.0%
TTM-5.1%YOY-12.2%+7.1%
TTM-5.1%5Y-5.7%+0.5%
5Y-5.7%10Y-0.9%-4.7%
1.1.3. Return on Equity

Shows how efficient Medical Developments International is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medical Developments International to the Drug Manufacturers - Specialty & Generic industry mean.
  • -6.9% Return on Equity means Medical Developments International generated $-0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Medical Developments International:

  • The MRQ is -6.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.9%TTM-6.9%0.0%
TTM-6.9%YOY-21.7%+14.8%
TTM-6.9%5Y-8.7%+1.9%
5Y-8.7%10Y-1.2%-7.6%

1.2. Operating Efficiency of Medical Developments International.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Medical Developments International is operating .

  • Measures how much profit Medical Developments International makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medical Developments International to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -62.7% means the company generated $-0.63  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Medical Developments International:

  • The MRQ is -62.7%. The company is operating very inefficient. -2
  • The TTM is -62.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-62.7%TTM-62.7%0.0%
TTM-62.7%YOY-71.5%+8.8%
TTM-62.7%5Y-27.8%-34.9%
5Y-27.8%10Y-7.7%-20.0%
1.2.2. Operating Ratio

Measures how efficient Medical Developments International is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.63 means that the operating costs are $1.63 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Medical Developments International:

  • The MRQ is 1.627. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.627. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.627TTM1.6270.000
TTM1.627YOY1.715-0.088
TTM1.6275Y1.304+0.323
5Y1.30410Y1.144+0.160

1.3. Liquidity of Medical Developments International.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Medical Developments International is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.75 means the company has $2.75 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Medical Developments International:

  • The MRQ is 2.750. The company is able to pay all its short-term debts. +1
  • The TTM is 2.750. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.750TTM2.7500.000
TTM2.750YOY3.279-0.529
TTM2.7505Y4.042-1.292
5Y4.04210Y2.924+1.117
1.3.2. Quick Ratio

Measures if Medical Developments International is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Medical Developments International to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.16 means the company can pay off $2.16 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Medical Developments International:

  • The MRQ is 2.161. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.161. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.161TTM2.1610.000
TTM2.161YOY2.542-0.382
TTM2.1615Y3.367-1.207
5Y3.36710Y2.278+1.090

1.4. Solvency of Medical Developments International.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Medical Developments International assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Medical Developments International to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.26 means that Medical Developments International assets are financed with 25.7% credit (debt) and the remaining percentage (100% - 25.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Medical Developments International:

  • The MRQ is 0.257. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.257. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.257TTM0.2570.000
TTM0.257YOY0.435-0.177
TTM0.2575Y0.405-0.148
5Y0.40510Y0.417-0.011
1.4.2. Debt to Equity Ratio

Measures if Medical Developments International is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Medical Developments International to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 34.6% means that company has $0.35 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Medical Developments International:

  • The MRQ is 0.346. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.346. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.346TTM0.3460.000
TTM0.346YOY0.769-0.423
TTM0.3465Y0.735-0.388
5Y0.73510Y0.787-0.053

2. Market Valuation of Medical Developments International

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Medical Developments International generates.

  • Above 15 is considered overpriced but always compare Medical Developments International to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -11.92 means the investor is paying $-11.92 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Medical Developments International:

  • The EOD is -8.463. Based on the earnings, the company is expensive. -2
  • The MRQ is -11.925. Based on the earnings, the company is expensive. -2
  • The TTM is -11.925. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.463MRQ-11.925+3.462
MRQ-11.925TTM-11.9250.000
TTM-11.925YOY-10.156-1.769
TTM-11.9255Y395.431-407.356
5Y395.43110Y488.886-93.455
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Medical Developments International:

  • The EOD is -1.965. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.768. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.768. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.965MRQ-2.768+0.804
MRQ-2.768TTM-2.7680.000
TTM-2.768YOY-7.907+5.138
TTM-2.7685Y-12.971+10.203
5Y-12.97110Y-22.305+9.333
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Medical Developments International is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Medical Developments International:

  • The EOD is 0.584. Based on the equity, the company is cheap. +2
  • The MRQ is 0.823. Based on the equity, the company is cheap. +2
  • The TTM is 0.823. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.584MRQ0.823-0.239
MRQ0.823TTM0.8230.000
TTM0.823YOY2.199-1.377
TTM0.8235Y6.573-5.751
5Y6.57310Y12.459-5.886
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Medical Developments International.

3.1. Funds holding Medical Developments International

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2021-02-28SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF0.05-32208--
Total 0.0503220800.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Medical Developments International compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2780.2780%-0.128+146%0.140+99%0.076+266%
Book Value Per Share--0.9420.9420%0.664+42%0.683+38%0.452+109%
Current Ratio--2.7502.7500%3.279-16%4.042-32%2.924-6%
Debt To Asset Ratio--0.2570.2570%0.435-41%0.405-37%0.417-38%
Debt To Equity Ratio--0.3460.3460%0.769-55%0.735-53%0.787-56%
Dividend Per Share--0.3060.3060%0.002+18878%0.153+100%0.081+275%
Eps---0.065-0.0650%-0.144+121%-0.068+4%-0.027-59%
Free Cash Flow Per Share---0.280-0.2800%-0.185-34%-0.122-56%-0.066-76%
Free Cash Flow To Equity Per Share--0.0450.0450%-0.183+505%0.052-14%0.028+59%
Gross Profit Margin--1.6821.6820%1.209+39%-2.464+246%-3.275+295%
Intrinsic Value_10Y_max---1.713--------
Intrinsic Value_10Y_min---3.780--------
Intrinsic Value_1Y_max---0.089--------
Intrinsic Value_1Y_min---0.258--------
Intrinsic Value_3Y_max---0.331--------
Intrinsic Value_3Y_min---0.885--------
Intrinsic Value_5Y_max---0.648--------
Intrinsic Value_5Y_min---1.626--------
Market Cap47467860.000-41%66886530.00066886530.0000%126005592.000-47%328218675.600-80%344055679.800-81%
Net Profit Margin---0.173-0.1730%-0.565+226%-0.234+35%-0.071-59%
Operating Margin---0.627-0.6270%-0.715+14%-0.278-56%-0.077-88%
Operating Ratio--1.6271.6270%1.715-5%1.304+25%1.144+42%
Pb Ratio0.584-41%0.8230.8230%2.199-63%6.573-87%12.459-93%
Pe Ratio-8.463+29%-11.925-11.9250%-10.156-15%395.431-103%488.886-102%
Price Per Share0.550-41%0.7750.7750%1.460-47%3.803-80%3.987-81%
Price To Free Cash Flow Ratio-1.965+29%-2.768-2.7680%-7.907+186%-12.971+369%-22.305+706%
Price To Total Gains Ratio0.942-41%1.3271.3270%-11.597+974%150.682-99%207.698-99%
Quick Ratio--2.1612.1610%2.542-15%3.367-36%2.278-5%
Return On Assets---0.051-0.0510%-0.122+139%-0.057+10%-0.009-82%
Return On Equity---0.069-0.0690%-0.217+214%-0.087+27%-0.012-83%
Total Gains Per Share--0.5840.5840%-0.126+122%0.292+100%0.157+271%
Usd Book Value--52074126.00052074126.0000%36693639.200+42%37763235.280+38%24958821.520+109%
Usd Book Value Change Per Share--0.1780.1780%-0.082+146%0.089+99%0.049+266%
Usd Book Value Per Share--0.6030.6030%0.425+42%0.438+38%0.289+109%
Usd Dividend Per Share--0.1960.1960%0.001+18878%0.098+100%0.052+275%
Usd Eps---0.042-0.0420%-0.092+121%-0.043+4%-0.017-59%
Usd Free Cash Flow---15472064.000-15472064.0000%-10205414.400-34%-6760958.960-56%-3658925.400-76%
Usd Free Cash Flow Per Share---0.179-0.1790%-0.118-34%-0.078-56%-0.042-76%
Usd Free Cash Flow To Equity Per Share--0.0290.0290%-0.117+505%0.034-14%0.018+59%
Usd Market Cap30398417.544-41%42834133.81242834133.8120%80693981.117-47%210191239.854-80%220333257.344-81%
Usd Price Per Share0.352-41%0.4960.4960%0.935-47%2.435-80%2.553-81%
Usd Profit---3592003.600-3592003.6000%-7945442.800+121%-3735325.120+4%-1481117.120-59%
Usd Revenue--20708614.80020708614.8000%14052297.200+47%15749101.040+31%12309832.840+68%
Usd Total Gains Per Share--0.3740.3740%-0.081+122%0.187+100%0.101+271%
 EOD+2 -6MRQTTM+0 -0YOY+27 -95Y+22 -1410Y+18 -18

4.2. Fundamental Score

Let's check the fundamental score of Medical Developments International based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.463
Price to Book Ratio (EOD)Between0-10.584
Net Profit Margin (MRQ)Greater than0-0.173
Operating Margin (MRQ)Greater than0-0.627
Quick Ratio (MRQ)Greater than12.161
Current Ratio (MRQ)Greater than12.750
Debt to Asset Ratio (MRQ)Less than10.257
Debt to Equity Ratio (MRQ)Less than10.346
Return on Equity (MRQ)Greater than0.15-0.069
Return on Assets (MRQ)Greater than0.05-0.051
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Medical Developments International based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5027.579
Ma 20Greater thanMa 500.594
Ma 50Greater thanMa 1000.736
Ma 100Greater thanMa 2000.792
OpenGreater thanClose0.560
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Total Other Income Expense Net -71-1,481-1,552-8,187-9,7399,526-21312,99412,781



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets109,486
Total Liabilities28,171
Total Stockholder Equity81,315
 As reported
Total Liabilities 28,171
Total Stockholder Equity+ 81,315
Total Assets = 109,486

Assets

Total Assets109,486
Total Current Assets42,762
Long-term Assets66,724
Total Current Assets
Cash And Cash Equivalents 24,661
Net Receivables 8,932
Inventory 8,378
Other Current Assets 791
Total Current Assets  (as reported)42,762
Total Current Assets  (calculated)42,762
+/-0
Long-term Assets
Property Plant Equipment 12,122
Goodwill 3,808
Intangible Assets 8,464
Long-term Assets Other 29,853
Long-term Assets  (as reported)66,724
Long-term Assets  (calculated)54,247
+/- 12,477

Liabilities & Shareholders' Equity

Total Current Liabilities15,548
Long-term Liabilities12,623
Total Stockholder Equity81,315
Total Current Liabilities
Short-term Debt 352
Accounts payable 13,324
Other Current Liabilities 1,589
Total Current Liabilities  (as reported)15,548
Total Current Liabilities  (calculated)15,265
+/- 283
Long-term Liabilities
Long term Debt Total 2,208
Capital Lease Obligations 2,560
Other Liabilities 2,242
Long-term Liabilities  (as reported)12,623
Long-term Liabilities  (calculated)7,010
+/- 5,613
Total Stockholder Equity
Common Stock105,729
Retained Earnings -30,154
Accumulated Other Comprehensive Income 5,740
Total Stockholder Equity (as reported)81,315
Total Stockholder Equity (calculated)81,315
+/-0
Other
Capital Stock105,729
Cash And Equivalents24,661
Cash and Short Term Investments 24,661
Common Stock Shares Outstanding 84,274
Current Deferred Revenue283
Liabilities and Stockholders Equity 109,486
Net Debt -22,101
Net Invested Capital 81,315
Net Tangible Assets 75,699
Net Working Capital 27,214
Property Plant and Equipment Gross 22,254
Short Long Term Debt Total 2,560



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-30
> Total Assets 
11,633
12,472
11,555
12,499
12,115
13,189
13,392
14,215
16,713
19,136
20,259
22,560
22,988
41,239
41,764
49,548
84,801
94,851
100,175
101,358
109,486
109,486101,358100,17594,85184,80149,54841,76441,23922,98822,56020,25919,13616,71314,21513,39213,18912,11512,49911,55512,47211,633
   > Total Current Assets 
2,902
3,745
2,835
3,264
3,037
3,602
3,439
4,409
6,192
6,687
4,923
5,578
4,835
16,051
9,879
8,747
35,354
25,957
47,387
34,369
42,762
42,76234,36947,38725,95735,3548,7479,87916,0514,8355,5784,9236,6876,1924,4093,4393,6023,0373,2642,8353,7452,902
       Cash And Cash Equivalents 
980
1,701
542
1,020
335
473
257
1,782
3,541
3,483
768
1,659
954
5,620
1,691
794
25,620
15,544
36,277
20,398
24,661
24,66120,39836,27715,54425,6207941,6915,6209541,6597683,4833,5411,7822574733351,0205421,701980
       Short-term Investments 
250
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000250
       Net Receivables 
745
636
678
769
1,247
2,025
1,692
981
1,633
2,048
2,342
1,823
1,819
7,520
5,232
4,287
6,384
4,115
4,985
6,246
8,932
8,9326,2464,9854,1156,3844,2875,2327,5201,8191,8232,3422,0481,6339811,6922,0251,247769678636745
       Inventory 
886
1,222
1,439
1,363
1,378
1,011
1,377
1,538
940
1,067
1,398
1,446
1,887
2,667
2,424
3,197
3,049
5,882
5,728
7,105
8,378
8,3787,1055,7285,8823,0493,1972,4242,6671,8871,4461,3981,0679401,5381,3771,0111,3781,3631,4391,222886
       Other Current Assets 
41
186
176
112
77
93
113
108
78
89
415
650
175
244
532
469
301
416
397
620
791
7916203974163014695322441756504158978108113937711217618641
   > Long-term Assets 
8,731
8,727
8,720
9,235
9,078
9,587
9,953
9,806
10,521
12,449
15,336
16,982
18,153
25,188
31,885
40,801
49,447
68,894
52,788
66,989
66,724
66,72466,98952,78868,89449,44740,80131,88525,18818,15316,98215,33612,44910,5219,8069,9539,5879,0789,2358,7208,7278,731
       Property Plant Equipment 
1,525
1,309
1,434
1,251
1,061
1,027
863
619
720
684
1,026
1,125
1,522
2,614
6,637
8,075
8,558
11,781
11,704
11,552
12,122
12,12211,55211,70411,7818,5588,0756,6372,6141,5221,1251,0266847206198631,0271,0611,2511,4341,3091,525
       Goodwill 
0
7,368
6,989
7,368
7,368
7,368
7,368
7,368
7,368
7,368
7,368
7,368
7,368
8,874
8,874
9,095
9,095
9,095
4,389
3,808
3,808
3,8083,8084,3899,0959,0959,0958,8748,8747,3687,3687,3687,3687,3687,3687,3687,3687,3687,3686,9897,3680
       Intangible Assets 
7,206
7,368
6,989
438
517
1,050
1,465
1,640
2,433
4,397
6,942
8,385
9,120
11,772
15,092
22,549
29,666
16,144
8,199
7,973
8,464
8,4647,9738,19916,14429,66622,54915,09211,7729,1208,3856,9424,3972,4331,6401,4651,0505174386,9897,3687,206
       Other Assets 
0
50
297
178
132
1,120
1,625
1,668
2,232
3,696
6,681
8,242
143
1,928
14,226
21,592
29,847
35,975
35,051
40,737
8,112
8,11240,73735,05135,97529,84721,59214,2261,9281438,2426,6813,6962,2321,6681,6251,120132178297500
> Total Liabilities 
4,131
4,098
3,155
2,627
1,094
1,388
1,578
1,503
2,258
2,967
4,515
6,736
5,581
22,214
20,164
28,507
40,213
51,513
31,873
44,060
28,171
28,17144,06031,87351,51340,21328,50720,16422,2145,5816,7364,5152,9672,2581,5031,5781,3881,0942,6273,1554,0984,131
   > Total Current Liabilities 
1,510
2,066
1,123
501
692
1,065
1,258
1,164
1,847
2,133
3,187
4,361
1,832
8,811
5,306
6,103
8,395
8,213
6,960
10,481
15,548
15,54810,4816,9608,2138,3956,1035,3068,8111,8324,3613,1872,1331,8471,1641,2581,0656925011,1232,0661,510
       Short-term Debt 
1,500
1,500
500
44
0
0
0
0
0
0
1,356
3,089
92
143
146
102
91
417
337
348
352
35234833741791102146143923,0891,356000000445001,5001,500
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
3,662
92
143
146
102
91
91
0
0
0
0009191102146143923,66200000000000
       Accounts payable 
0
202
229
182
225
723
691
661
590
999
1,238
746
810
1,989
1,785
2,063
2,030
3,841
3,302
9,368
13,324
13,3249,3683,3023,8412,0302,0631,7851,9898107461,2389995906616917232251822292020
       Other Current Liabilities 
0
352
387
263
464
342
567
503
1,257
1,134
593
526
930
4,907
1,298
1,520
3,753
1,561
3,253
683
1,589
1,5896833,2531,5613,7531,5201,2984,9079305265931,1341,2575035673424642633873520
   > Long-term Liabilities 
2,621
2,032
2,032
2,126
402
323
320
339
411
834
1,328
2,375
3,749
13,403
14,858
22,404
31,818
43,300
24,913
33,579
12,623
12,62333,57924,91343,30031,81822,40414,85813,4033,7492,3751,3288344113393203234022,1262,0322,0322,621
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
1,019
338
283
9,150
91
2,939
2,712
2,465
2,208
2,2082,4652,7122,939919,1502833381,019000000000000
       Other Liabilities 
0
30
32
126
152
323
320
339
349
359
379
388
2,730
13,065
14,575
13,254
31,727
30,269
22,201
21,976
2,242
2,24221,97622,20130,26931,72713,25414,57513,0652,73038837935934933932032315212632300
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
8,138
8,786
10,103
13,165
20,510
27,718
33,869
32,814
35,125
32,701
32,70135,12532,81433,86927,71820,51013,16510,1038,7868,13800000000000
> Total Stockholder Equity
7,502
8,374
8,400
9,872
11,021
11,801
11,814
12,712
14,455
16,169
15,744
15,824
17,407
19,025
21,600
21,041
44,588
43,338
68,302
57,298
81,315
81,31557,29868,30243,33844,58821,04121,60019,02517,40715,82415,74416,16914,45512,71211,81411,80111,0219,8728,4008,3747,502
   Common Stock
7,502
7,893
7,893
8,092
8,092
7,985
7,293
7,293
7,293
9,354
10,559
10,946
10,946
11,916
15,008
16,121
40,410
40,954
76,895
76,992
105,729
105,72976,99276,89540,95440,41016,12115,00811,91610,94610,94610,5599,3547,2937,2937,2937,9858,0928,0927,8937,8937,502
   Retained Earnings Total Equity000000000000000000000
   Accumulated Other Comprehensive Income 
0
-118
-335
147
89
152
185
204
204
103
-13
-33
21
257
264
711
1,508
1,957
3,545
4,851
5,740
5,7404,8513,5451,9571,50871126425721-33-1310320420418515289147-335-1180
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
-33
21
257
264
711
1,508
0
-64,757
-52,447
-75,575
-75,575-52,447-64,75701,50871126425721-3300000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.